An observational study in Vasoplegic Syndrome of Cardiac Surgery, sponsored by Centre Hospitalier Universitaire, Amiens. Active, not recruiting at 1 site in France. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-06-15.
Sponsored by Centre Hospitalier Universitaire, Amiens · Observational
Vasoplasmic syndrome in cardiac surgery is one of the major postoperative complications.This syndrome is characterized by persistent low blood pressure despite an optimization of preload and inotropism.
48 studies on the registry are indexed under Vasoplegia; 19 are open to participants now.
This study's enrollment of 1,113 is above the median of 200 across 19 observational studies indexed under Vasoplegia.
Browse Vasoplegia studies →Centre Hospitalier Universitaire, Amiens is the lead sponsor of 586 studies on the registry; 185 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All consecutive cardiac surgical patients who meeet inclusion criteria with cardiopulmonary bypass
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Vasoplegic syndrome
Patients suffering of vasoplegic syndrom defined by persitent arterial hypotension (MAP below70 mmHg) despite fluid rescucitation, normal or high cardiac output, and treated more than 4 hours with norepinephrine
Time frame: 30 days
Post operative organ failure
every post opertaive organ failure: brain, digestive, renal, cardiac...
Time frame: 30 days
Arrythmia
atrial fibrillation, ventricular tachycardia, ventricular flutter
Time frame: 30 days
Inotropic use
dobutamine, levosimendan, phosphodiesterase
Time frame: 30 days
cardiac damage
troponine I release
Time frame: 1 day
Post operative Sepsis
postoperative sepsis: pneumonae, blood stream, mediastinis, urinary track, other
Time frame: 30 days
Hemorrhage
postopertaive blood loss defined by the Universal definition of perioperative bleeding
Time frame: 30 days
Blood transfusion
red blood cell transfusion, plaquette, plasma
Time frame: 30 days
ICU stays
Stay at ICU until patient discharge
Time frame: 30 days
Hospital stays
hospital stays until patient discharge
Time frame: 30 days
Death
Death of any cause
Time frame: one year
This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire, Amiens →